Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis

详细信息    查看全文

• 作者：Julián E. Mu?oz ; Vinicius D. Luft ; Juliana Amorim ; Adriana Magalh?es…
• 关键词：P. brasiliensis ; Anergy ; Chemotherapy ; P10 immunization
• 刊名：Mycopathologia
• 出版年：2014
• 出版时间：October 2014
• 年：2014
• 卷：178
• 期：3-4
• 页码：177-188
• 全文大小：1,116 KB
• 参考文献：1. Restrepo A, McEwen JG, Casta?eda E. The habitat of / Paracoccidioides brasiliensis: how far from solving the riddle? Med Mycol. 2001;39:233-1. CrossRef
  2. Brummer E, Casta?eda E, Restrepo A. / Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993;6:89-17.
  3. Franco M. Host-parasite relationships in paracoccidioidomycosis. J Med Vet Mycol. 1987;25:5-8. CrossRef
  4. Calich VL, Singer-Vermes LM, Russo M, et al. Immunogenetics in paracoccidioidomycosis. In: Franco M, Lacaz CS, Restrepo A, del Negro G, editors. Paracoccidioidomycosis. Boca Raton: CRC Press; 1994. p. 151-3.
  5. Casta?eda E, Brummer E, Pappagianis D, et al. Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice. Infect Immun. 1988;56:1771-.
  6. Singer-Vermes LM, Caldeira CB, Burger E, et al. Experimental murine paracoccidioidomycosis: relationship among the dissemination of the infection, humoral and cellular immune responses. Clin Exp Immunol. 1993;94:75-. CrossRef
  7. Brummer E, Hanson LH, Restrepo A, et al. In vivo and in vitro activation of pulmonary macrophages by IFN-γ for enhanced killing of / Paracoccidioides brasiliensis or / Blastomyces dermatitidis. J Immunol. 1988;140:2786-.
  8. Puccia R, Travassos LR. 43-Kilodalton glycoprotein from / Paracoccidioides brasiliensis: immunochemical reactions with sera from patients with paracoccidioidomycosis, histoplasmosis, or Jorge Lobo’s disease. J Clin Microbiol. 1991;29:1610-.
  9. Vicentini AP, Gesztesi JL, Franco MF, et al. Binding of / Paracoccidioides brasiliensis to laminin through surface glycoprotein gp43 leads to enhancement of fungal pathogenesis. Infect Immun. 1994;62:1465-.
  10. Taborda CP, Juliano MA, Puccia R, et al. Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of / Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun. 1998;66:786-3.
  11. Rodrigues EG, Travassos LR. Nature of the reactive epitopes in / Paracoccidioides brasiliensis polysaccharide antigen. J Med Vet Mycol. 1994;32:77-1. CrossRef
  12. Iwai LK, Yoshida M, Sadahiro A, et al. T-cell recognition of / Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clin Vaccine Immunol. 2007;14:474-. CrossRef
  13. Shikanai-Yasuda MA, Telles-Filho FQ, Mendes RP, et al. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006;39:297-10. CrossRef
  14. Hahn RC, Concei??o YTM, Santos NL, Ferreira JF, Hamdan JS. Disseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulfamethoxazole. Mycoses. 2003;46:342-. CrossRef
  15. Shikanai-Yasuda MA, Duarte MI, Nunes DF, et al. Paracoccidioidomycosis in a renal transplant recipient. J Med Vet Mycol. 1995;6:411-. CrossRef
  16. Ribeiro L, Hahn RC, Favalessa OC, Tadano T, Fontes CJFF. Systemic mycosis: factors associated with death among patients infected with the human immunodeficiency virus, Cuiabá, State of Mato Grosso, Brazil, 2005-008. Rev Soc Bras Med Trop. 2009;6:698-05. CrossRef
  17. Morejón KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg. 2009;80:359-6.
  18. Bellissimo-Rodrigues F, Vitali LH, Martinez R. Serological diagnosis of paracoccidioidomycosis in HIV-coinfected patients. Mem Inst Oswaldo Cruz. 2010;105:904-. CrossRef
  19. Chung YJ, Lee JI, Chong S, et al. Anti-proliferative effect and action mechanism of dexamethasone in human medullary thyroid cancer cell line. Endocr Res. 2011;36:149-7. CrossRef
  20. Marques AF, da Silva MB, Juliano MA, et al. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of / Paracoccidioides brasiliensis. Microbes Infect. 2008;10:1251-. CrossRef
  21. Restrepo A, Arango MD. / In vitro susceptibility testing of / paracoccidioides brasiliensis to sulfonamides. Antimicrob Agents Chemother. 1980;18:190-. CrossRef
  22. Magalh?es A, Ferreira KS, Almeida SR, et al. Prophylactic and Therapeutic Vaccination Using Dendritic Cells Primed with Peptide 10 Derived from the 43-Kilodalton Glycoprotein of / Paracoccidioides brasiliensis. Clin Vaccine Immunol. 2011;19:23-. CrossRef
  23. Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4?+?lymphocytes. J Immunol. 1997;158:5589-5.
  24. Li Y, Ito N, Suzuki T, et al. Dexamethasone inhibits nitric oxide-mediated cytotoxicity via effects on both macrophages and target cells. Immunopharmacology. 1995;30:177-6. CrossRef
  25. Travassos LR, Goldman G, Taborda CP, Puccia R. Insights in / Paracoccidioides brasiliensis pathogenicity. In: Kavanagh K, editor. New insights in medical mycology. Dordrecht: Springer; 2007. p. 241-5. CrossRef
  26. Souto JT, Figueiredo F, Furlanetto A, et al. Interferon-gamma and tumor necrosis factor-alpha determine resistance to / Paracoccidioides brasiliensis infection in mice. Am J Pathol. 2000;156:1811-0. CrossRef
  27. Travassos LR, Taborda CP, Iwai LK, et al. The gp43 from / Paracoccidioides brasiliensis: a major diagnostic antigen and vaccine candidate. In: Domer JE, Kobayashi GS, editors. The mycota XII human fungal pathogens. Berlin: Springer; 2004. p. 279-6. CrossRef
  28. de Castro LF, Ferreira MC, da Silva RM, et al. Characterization of the immune response in human paracoccidioidomycosis. J Infect. 2013;67:470-5. CrossRef
  29. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4:11-4. CrossRef
  30. González A, Gregori WD, Vélez D, et al. Nitric oxide participation in the fungicidal mechanism of IFN-γ-activated murine macrophages against / Paracoccidioides brasiliensis conidia. Infect Immun. 2000;68:2546-2. CrossRef
  31. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-2. CrossRef
  32. Silvana dos Santos S, Ferreira KS, Almeida SR. / Paracoccidioides brasiliensis-induced migration of dendritic cells and subsequent T-cell activation in the lung- draining lymph nodes. PLoS One. 2011;5:e19690. CrossRef
  33. Pina A, Saldiva PH, Restrepo LEC, Calich VLG. Neutrophil role in pulmonary paracoccidioidomycosis depends on the resistance pattern of hosts. J Leukoc Biol. 2006;79:1202-3. CrossRef
  34. Naranjo TW, Lopera DE, Diaz-Granados LR, et al. Combined itraconazole-pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice. Pulm Pharmacol Ther. 2011;24:81-1. CrossRef
  35. Mamoni RL, Blotta MH. Flow-cytometric analysis of cytokine production in human paracoccidioidomycosis. Cytokine. 2006;35:207-6. CrossRef
  
• 作者单位：Julián E. Mu?oz (1)
  Vinicius D. Luft (1)
  Juliana Amorim (1)
  Adriana Magalh?es (1)
  Luciana Thomaz (1)
  Joshua D. Nosanchuk (2)
  Luiz R. Travassos (3)
  Carlos P. Taborda (1) (4)
  
  1. Department of Microbiology, Institute of Biomedical Sciences, University of S?o Paulo, Av. Prof. Lineu Prestes, 1374, S?o Paulo, SP, 05008-900, Brazil
  2. Departments of Medicine, and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA
  3. Department of Microbiology, Immunology and Parasitology, Federal University of S?o Paulo, S?o Paulo, SP, Brazil
  4. Laboratory of Medical Mycology-LIM53/IMTSP, University of S?o Paulo, S?o Paulo, SP, Brazil
  
• ISSN：1573-0832

文摘

Paracoccidioidomycosis is a systemic granulomatous disease caused by Paracoccidioides spp. A peptide from the major diagnostic antigen gp43, named P10, induces a T-CD4+?helper-1 immune response in mice and protects against intratracheal challenge with virulent P. brasiliensis. Previously, we evaluated the efficacy of the P10 peptide alone or combined with antifungal drugs in mice immunosuppressed and infected with virulent isolate of P. brasiliensis. In the present work, our data suggest that P10 immunization leads to an effective cellular immune response associated with an enhanced T cell proliferative response. P10-stimulated splenocytes increased nitric oxide (NO) production and induced high levels of IFN-γ, IL-1β and IL-12. Furthermore, significantly increased concentrations of pro-inflammatory cytokines were also observed in lung homogenates of immunized mice. P10 immunization was followed by minimal fibrosis in response to infection. Combined with antifungal drugs, P10 immunization most significantly improved survival of anergic infected mice. Administration of either itraconazole or sulfamethoxazole/trimethoprim together with P10 immunization resulted in 100?% survival up to 200?days post-infection, whereas untreated mice died within 80?days. Hence, our data show that P10 immunization promotes a strong specific immune response even in immunocompromised hosts and thus P10 treatment represents a powerful adjuvant therapy to chemotherapy.